ArticleJournal for immunotherapy of cancer2025

Risk of disease progression after discontinuing immunotherapy in 105 patients with Merkel cell carcinoma who responded to PD-1 pathway blockade.

Lisa Tachiki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.